Cargando…
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-acquired infections. It is intrinsically resistant to many antimicrobial agents and additional acquired resistance further complicates the management of such infections. High rates of combined antimicrobial...
Autores principales: | Losito, Angela Raffaella, Raffaelli, Francesca, Del Giacomo, Paola, Tumbarello, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137685/ https://www.ncbi.nlm.nih.gov/pubmed/35625223 http://dx.doi.org/10.3390/antibiotics11050579 |
Ejemplares similares
-
XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?
por: Del Giacomo, Paola, et al.
Publicado: (2022) -
Traditional Chinese Medicine is an Alternative Therapeutic Option for Treatment of Pseudomonas aeruginosa Infections
por: Pang, Zheng, et al.
Publicado: (2021) -
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
por: Giovagnorio, Federico, et al.
Publicado: (2023) -
Multidrug-Resistant Pseudomonas Aeruginosa Bloodstream Infections: Analysis of Trends in Prevalence and Epidemiology
por: Tacconelli, Evelina, et al.
Publicado: (2002) -
Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)